Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
2021 · Molecular Cell · 236 citations
https://doi.org/10.1016/j.molcel.2021.03.037
X
Xiaoming Dai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
2.6K
Citations
24
h-index
32
i10-index
Xiaoming Dai is an academic researcher from Kunming Medical University. The author has contributed to research in topics: Hippo pathway signaling and YAP/TAZ & Cancer-related molecular mechanisms research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 24, co-authored 57 publications.
ORCID: 0000-0001-9671-8137Papers by this author
worksPhosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis
2013 · Journal of Biological Chemistry · 154 citations
https://doi.org/10.1074/jbc.m113.518019
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
2017 · Cancer Research · 141 citations
https://doi.org/10.1158/0008-5472.can-17-0391
PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity
2023 · Nature Communications · 68 citations
https://doi.org/10.1038/s41467-023-38443-3
S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
2022 · Nature Communications · 55 citations
https://doi.org/10.1038/s41467-022-28910-8
Energy sensor AMPK gamma regulates translation via phosphatase PPP6C independent of AMPK alpha
2024 · Molecular Cell · 3 citations
https://doi.org/10.1016/j.molcel.2024.02.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat